Jinghan Song | Bioactive Materials and Genomic Research | Best Scholar Award

Posted on by PencisLeave a Comment on Jinghan Song | Bioactive Materials and Genomic Research | Best Scholar Award

Ms. Jinghan Song | Bioactive Materials and Genomic Research | Best Scholar Award

The Fourth Military University  | China

Author Profile 

Scopus

EARLY ACADEMIC PURSUITS

Jinghan Song demonstrated exceptional academic prowess early on, laying a solid foundation during their undergraduate studies at Xi’an Jiaotong University. With a Bachelor of Science in Medicine, Jinghan excelled in major courses such as Bioinformatics, Physiology, Immunology, and Pathology, achieving an impressive average score of 90.1/100.

PROFESSIONAL ENDEAVORS

Building upon their undergraduate success, Jinghan pursued a Master of Science in Medicine at The Fourth Military Medical University. Throughout their academic journey, they delved into advanced topics including Advances in Cell Biology, Electron Microscopy, and Tissue Engineering and Regenerative Medicine. Their commitment to excellence is evident in their remarkable average score of 85.47/100.

CONTRIBUTIONS AND RESEARCH FOCUS ON BIOACTIVE MATERIALS AND GENOMIC RESEARCH

Jinghan has contributed significantly to the field of biomedical research, notably as a member of projects focusing on innovative materials and their applications. Noteworthy projects include the development of collagen materials cross-linked with DNA and the preparation method and application of polyphosphate modified collagen material. These endeavors underscore Jinghan's dedication to advancing biomedical science through innovative research.

IMPACT AND INFLUENCE

Jinghan's research has garnered attention within the academic community, as evidenced by their participation in prestigious academic conferences such as the 25th Academic Conference of Chinese Stomatological Association, where they presented posters and gave oral presentations. Their contributions have earned them recognition, including the First Prize for Poster at the aforementioned conference.

ACADEMIC CITATIONS

Jinghan's work has the potential for significant academic impact, as indicated by their involvement in patent projects and participation in academic conferences. Their research outputs may serve as valuable references for future studies in the fields of biomaterials and regenerative medicine.

LEGACY AND FUTURE CONTRIBUTIONS

As an outstanding graduate of Xi’an Jiaotong University and a recipient of multiple scholarships and awards, Jinghan is poised to make enduring contributions to the field of medicine and biomedical research. Their dedication to academic excellence and innovative research methodologies positions them as a promising scholar with the potential to shape the future of healthcare and biotechnology.

Notable Publications

Advances in materials-based therapeutic strategies against osteoporosis 2023(20)

Engineered extracellular vesicles: Regulating the crosstalk between the skeleton and immune system 2022(7)

Inflammation-associated ectopic mineralization 2023(1)

 

 

Hongmeng Su | Gene Regulations | Best Researcer Award

Posted on by PencisLeave a Comment on Hongmeng Su | Gene Regulations | Best Researcer Award

Dr. Hongmeng Su | Gene Regulations and Epigenetics |  Best Researcer Award

Southeast University | China

Author Profile

Scopus

EARLY ACADEMIC PURSUITS

Hongmeng Su embarked on an academic journey marked by a strong foundation in bioengineering, which laid the groundwork for subsequent achievements. Graduating with a Bachelor of Engineering in Bioengineering from Nanjing Agriculture University in 2019, Su's early academic pursuits showcased a dedication to biological sciences and a burgeoning interest in research.

PROFESSIONAL ENDEAVORS

Transitioning seamlessly from undergraduate to graduate studies, Su pursued a Master of Science in Biology at the School of Life Science and Technology, Southeast University, from 2019 to 2021. This period not only honed Su's research skills but also provided a platform for academic growth and exploration in the field of biology.

CONTRIBUTIONS AND RESEARCH FOCUS ON GENE REGULATIONS AND EPIGENETICS

Su's contributions to the field of medical genetics and developmental biology are underscored by a multifaceted approach to understanding the molecular mechanisms driving hepatocellular carcinogenesis. Through meticulous research endeavors, Su has delved into the intricate interplay between non-coding RNA, transcription factors, and carcinogenesis, shedding light on key pathways implicated in cancer progression and metastasis.

IMPACT AND INFLUENCE

Su's research findings have garnered recognition and accolades, affirming the significance of their contributions to the scientific community. Notably, Su's report on the combined analysis of m6A and m5C RNA methylation modulators received honorable mention at the 10th Member Congress and Academic Seminar of Jiangsu Genetic Association, showcasing the impact of their work on hepatocellular carcinoma prognosis.

ACADEMIC CITATIONS

Su's scholarly endeavors have contributed to the advancement of knowledge in medical genetics, developmental biology, and cancer research. Their publications serve as a testament to their dedication to scientific inquiry and the dissemination of impactful findings within the academic community.

LEGACY AND FUTURE CONTRIBUTIONS

As a Ph.D. candidate at the Department of Medical Genetics & Developmental Biology, School of Medicine, Southeast University, Su's legacy is characterized by a commitment to unraveling the complexities of hepatocellular carcinogenesis. Armed with a diverse skill set encompassing molecular and cellular experimentation, bioinformatics analysis, and statistical modeling, Su is poised to make enduring contributions to the field of cancer biology and beyond. Their future endeavors hold the promise of further elucidating the molecular underpinnings of cancer progression, informing novel therapeutic strategies, and ultimately, advancing human health.

Notable Publications

TRERNA1 upregulation mediated by HBx promotes sorafenib resistance and cell proliferation in HCC via targeting NRAS by sponging miR-22-3p 2021(35)

ETV4 facilitates angiogenesis in hepatocellular carcinoma by upregulating MMP14 expression

Prognostic value of PD-L1 expression combined with hypoxia-associated immunosuppression in hepatocellular carcinoma